Related Experiment Videos
The use of beta-blockers in unstable angina: comparison with calcium channel blocking agents
1Department of Medicine, University of Frankfurt am Main, F.R.G.
Insights
Unstable angina involves plaque buildup and spasms in coronary arteries. Calcium channel blockers and organic nitrates effectively improve blood flow and are safe for patients, often negating the need for beta-blockers.
Area of Science:
- Cardiology
- Vascular Medicine
- Pharmacology
Background:
- Unstable angina stems from critical narrowing of coronary arteries due to atherosclerosis, thrombus formation, and vasospasm.
- Coronary vasomotor tone significantly influences myocardial blood flow regulation during normal and ischemic states.
- Beta-2 receptor blockade can cause coronary vasoconstriction, particularly in susceptible patients.
Purpose of the Study:
- To review the pathophysiology of unstable angina.
- To outline therapeutic strategies for increasing coronary blood flow.
- To evaluate the role of specific drug classes in managing coronary vasospasm.
Main Methods:
- Review of pathophysiology of unstable angina.
- Analysis of therapeutic goals including vasodilation, thrombolysis, and antithrombotic strategies.
- Evaluation of clinical trial data on calcium antagonists, organic nitrates, and beta-blockers.
Main Results:
- Calcium channel blockers and organic nitrates are demonstrated as safe and effective in patients with vasospastic reactions.
- Combined therapy with nitrates and verapamil-type calcium channel blockers may obviate the need for beta-blockers.
- Understanding coronary vasomotor tone is crucial for managing myocardial blood flow.
Conclusions:
- Therapeutic strategies for unstable angina should address vasodilation and antithrombotic needs.
- Calcium channel blockers and organic nitrates are key treatments for vasospastic angina.
- Beta-blockers may be unnecessary when nitrates are combined with specific calcium channel blockers.
Abstract:
The pathophysiology of unstable angina comprises critical narrowing of large coronary vessels by advanced atherosclerotic plaques, thrombus formation, and vasospastic reactions. Therapeutic goals aim primarily at an increase of flow and include vasodilation, thrombolytic strategies, and antithrombotic procedures (anticoagulation, antiaggregation). In the complex system of myocardial blood flow regulation, under normal and ischemic conditions, coronary vasomotor tone plays an important role. Especially in patients prone to vasospastic reactions, coronary vessels can be constricted by blockade of beta 2-receptors, which can lead to undesirable effects. Controlled clinical trials have clearly demonstrated that calcium antagonistic drugs and organic nitrates are safe and beneficially effective in such patients. beta-Blockers are usually not necessary if nitrates are combined with a calcium channel blocker of the verapamil type.